Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Setuximab

Were you looking for information on Cetuximab? Setuximab is a common misspelling of cetuximab.
 
The U.S. Food and Drug Administration has approved cetuximab (Erbitux®) for the treatment of squamous cell carcinoma of the head and neck. It is also approved to treat certain types of advanced colorectal cancer. This drug is given by injection into a vein, and side effects may include fatigue, nausea, and skin reactions. It may be given alone or in combination with other treatments, like radiation.
 
(Click Cetuximab to learn more, including possible drug interactions, what to discuss with the healthcare provider prescribing it, and what to do in cases of overdose. You can also click any of the links in the box to the right for more information.)
 
7 Natural Ways to Reduce Your Cancer Pain
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.